ERRATUM article

Front. Microbiol., 22 May 2025

Sec. Infectious Agents and Disease

Volume 16 - 2025 | https://doi.org/10.3389/fmicb.2025.1605861

Erratum: Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis

This article is an erratum on:

  1. Immunogenicity and Protective Efficacy of a Multi-antigenic Adenovirus-based Vaccine Candidate against Mycobacterium tuberculosis

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis

by Yun, J.-S., Shin, E., Lee, Y.-R., Lee, J.-A., Lee, H., Kim, J.-S., Shin, S. J., Ha, S.-J., Lee, S.-W., Kim, D., Yoo, J.-S., and Jeong, H.-S. (2025). Front. Microbiol. 16:1492268. doi: 10.3389/fmicb.2025.1492268

Due to a production error, Figure 8 was not included in the article. Figure 8 and its caption appears below.

Figure 8
www.frontiersin.org

Figure 8. Functional annotation analysis of the DEGs at each time point. Functional annotation analysis of the DEGs [fold change: 2, normalized data (log2): 4, p-value: 0.05] identified between rAd-TB4 vs. BCG based on gene ontology (GO) was performed using the DAVID 6.7 database at (A) pre-infection, (B) 1 week post-infection (p.i.1week), and (C) 4 weeks post-infection (p.i.4weeks).

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: pulmonary tuberculosis, BCG vaccine, adenovirus vector, multi-antigenic vaccine, immunization, mouse model, immune response

Citation: Frontiers Production Office (2025) Erratum: Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis. Front. Microbiol. 16:1605861. doi: 10.3389/fmicb.2025.1605861

Received: 04 April 2025; Accepted: 04 April 2025;
Published: 22 May 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.